BIOMAT Database Logo BIOMAT Database Logo

Is cyclic low dose cyproterone acetate and ethinyloestradiol effective in acne? 1983

J R Marsden, and S Shuster, and F Lyons

UI MeSH Term Description Entries
D003534 Cyproterone An anti-androgen that, in the form of its acetate (CYPROTERONE ACETATE), also has progestational properties. It is used in the treatment of hypersexuality in males, as a palliative in prostatic carcinoma, and, in combination with estrogen, for the therapy of severe acne and hirsutism in females. Cyproterone, 1alpha,2 alpha,9 beta,10 alpha-Isomer
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004997 Ethinyl Estradiol A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES. 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alpha)-,Ethynyl Estradiol,Estinyl,Ethinyl Estradiol Hemihydrate,Ethinyl Estradiol, (8 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,17 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,9 beta,13 alpha,14 beta)-Isomer,Ethinyl Estradiol, (9 beta,17 alpha)-Isomer,Ethinyl-Oestradiol Effik,Ethinylestradiol Jenapharm,Ethinyloestradiol,Lynoral,Microfollin,Microfollin Forte,Progynon C,Estradiol, Ethinyl,Estradiol, Ethynyl,Ethinyl Oestradiol Effik,Hemihydrate, Ethinyl Estradiol,Jenapharm, Ethinylestradiol
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000152 Acne Vulgaris A chronic disorder of the pilosebaceous apparatus associated with an increase in sebum secretion. It is characterized by open comedones (blackheads), closed comedones (whiteheads), and pustular nodules. The cause is unknown, but heredity and age are predisposing factors. Acne
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012629 Sebum The oily substance secreted by SEBACEOUS GLANDS. It is composed of KERATIN, fat, and cellular debris. Sebums
D017373 Cyproterone Acetate An agent with anti-androgen and progestational properties. It shows competitive binding with dihydrotestosterone at androgen receptor sites. Androcur,Cyproterone Acetate, (1 alpha,2 alpha)-Isomer,Cyproterone Acetate, (1 alpha,2 alpha,9 beta,10 alpha)-Isomer,Cyproterone Acetate, (17 alpha)-Isomer

Related Publications

J R Marsden, and S Shuster, and F Lyons
Cyclic cyproterone/ethinyloestradiol in acne.
October 1983, Lancet (London, England),
J R Marsden, and S Shuster, and F Lyons
Cyclic cyproterone/ethinyloestradiol for acne.
August 1983, Lancet (London, England),
J R Marsden, and S Shuster, and F Lyons
Cyclic cyproterone/ethinyloestradiol for acne.
October 1983, Lancet (London, England),
J R Marsden, and S Shuster, and F Lyons
Prescribing pitfalls: cyproterone acetate with ethinyloestradiol.
July 2000, Community nurse,
J R Marsden, and S Shuster, and F Lyons
Efficacy of low-dose cyproterone acetate compared with minocycline in the treatment of acne vulgaris.
September 1987, Clinical and experimental dermatology,
J R Marsden, and S Shuster, and F Lyons
Hepatocellular carcinoma after treatment with cyproterone acetate combined with ethinyloestradiol.
February 1995, Lancet (London, England),
J R Marsden, and S Shuster, and F Lyons
Low-Dose Cyproterone Acetate Treatment for Transgender Women.
July 2021, The journal of sexual medicine,
J R Marsden, and S Shuster, and F Lyons
Efficacy of combined ethinyloestradiol (0.035 mg) and cyproterone acetate (2 mg) in acne and hirsutism in women with polycystic ovary syndrome.
November 1997, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology,
J R Marsden, and S Shuster, and F Lyons
Treatment of hirsutism and acne with cyproterone acetate.
May 1986, Clinics in endocrinology and metabolism,
J R Marsden, and S Shuster, and F Lyons
Oral contraceptives and cyproterone acetate in female acne treatment.
January 1998, Dermatology (Basel, Switzerland),
Copied contents to your clipboard!